Nucleic Acids Research, 2003, Vol. 31, No. 20 5817-5830
© 2003 Oxford University Press
Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA
Department of Gene and Protein Therapeutics, Discovery Research, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK
*To whom correspondence should be addressed. Tel: +44 1438 764976; Fax: +44 1438 768091; Email: irc22275{at}gsk.com
Present address:
Kirsten M. L. Hertoghs, Department of Developmental Biology, University of Utrecht, The Netherlands
The available reagents for the attachment of functional moieties to plasmid DNA are limiting. Most reagents bind plasmid DNA in a non-sequence- specific manner, with undefined stoichiometry, and affect DNA charge and delivery properties or involve chemical modifications that abolish gene expression. The design and ability of oligonucleotides (ODNs) containing locked nucleic acids (LNAs) to bind supercoiled, double-stranded plasmid DNA in a sequence-specific manner are described for the first time. The main mechanism for LNA ODNs binding plasmid DNA is demonstrated to be by strand displacement. LNA ODNs are more stably bound to plasmid DNA than similar peptide nucleic acid (PNA) clamps for procedures such as particle-mediated DNA delivery (gene gun). It is shown that LNA ODNs remain associated with plasmid DNA after cationic lipid-mediated transfection into mammalian cells. LNA ODNs can bind to DNA in a sequence-specific manner so that binding does not interfere with plasmid conformation or gene expression. Attachment of CpG-based immune adjuvants to plasmid by hybrid phosphorothioateLNA ODNs induces tumour necrosis factor-
production in the macrophage cell line RAW264.7. This observation exemplifies an important new, controllable methodology for adding functionality to plasmids for gene delivery and DNA vaccination.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. J. Yang, L. Wang, Y. Wu, Y. Kim, C. D. Medley, H. Lin, and W. Tan Synthesis and investigation of deoxyribonucleic acid/locked nucleic acid chimeric molecular beacons Nucleic Acids Res., June 9, 2007; 35(12): 4030 - 4041. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ge, J. E. Heinonen, M. G. Svahn, A. J. Mohamed, K. E. Lundin, and C. I. E. Smith Zorro locked nucleic acid induces sequence-specific gene silencing FASEB J, June 1, 2007; 21(8): 1902 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brunet, M. Corgnali, L. Perrouault, V. Roig, U. Asseline, M. D. Sorensen, B. R. Babu, J. Wengel, and C. Giovannangeli Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities Nucleic Acids Res., July 27, 2005; 33(13): 4223 - 4234. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brunet, P. Alberti, L. Perrouault, R. Babu, J. Wengel, and C. Giovannangeli Exploring Cellular Activity of Locked Nucleic Acid-modified Triplex-forming Oligonucleotides and Defining Its Molecular Basis J. Biol. Chem., May 20, 2005; 280(20): 20076 - 20085. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Nulf and D. Corey Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs) Nucleic Acids Res., July 19, 2004; 32(13): 3792 - 3798. [Abstract] [Full Text] [PDF] |
||||


